Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet Lysate vs Platelet-rich Plasma for Knee Osteoarthritis
NCT03734900Phase 4Recruiting
- Sponsor
- National Taiwan University Hospital
- Start
- May 2018
- Primary completion
- May 2027
- Modality
- Blood Coagulation Factors
- Countries
- 1
01
Overview
Phase 4, randomised trial of platelet lysate and platelet-rich plasma in osteoarthritis (OA) (3 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Pain score at 24 weeks. Started May 2018; status: recruiting.
02
Drugs
platelet lysateplatelet-rich plasma
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03734900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03734900.